- Investing Ideas
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
16
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
16 companies
Ascendis Pharma
Market Cap: US$13.2b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$220.90
7D
-2.9%
1Y
39.6%
Madrigal Pharmaceuticals
Market Cap: US$10.2b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$461.93
7D
4.5%
1Y
38.4%
Insmed
Market Cap: US$30.0b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$148.31
7D
3.9%
1Y
93.7%
Alnylam Pharmaceuticals
Market Cap: US$40.9b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$328.70
7D
4.4%
1Y
22.1%
BeOne Medicines
Market Cap: US$31.4b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$283.45
7D
0.3%
1Y
7.9%
BridgeBio Pharma
Market Cap: US$13.3b
A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.
BBIO
US$71.61
7D
2.1%
1Y
98.4%
Ionis Pharmaceuticals
Market Cap: US$11.5b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$72.70
7D
1.4%
1Y
130.9%
AbbVie
Market Cap: US$363.0b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$207.18
7D
-0.6%
1Y
2.9%
Jazz Pharmaceuticals
Market Cap: US$11.4b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$189.08
7D
4.8%
1Y
44.5%
Eli Lilly
Market Cap: US$808.0b
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$916.31
7D
-0.2%
1Y
10.8%
BioMarin Pharmaceutical
Market Cap: US$10.4b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$55.59
7D
0.3%
1Y
-22.2%
Natera
Market Cap: US$27.6b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$197.37
7D
-0.2%
1Y
31.7%
Royalty Pharma
Market Cap: US$26.3b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$47.03
7D
2.7%
1Y
49.0%
Viatris
Market Cap: US$15.4b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$13.50
7D
-1.7%
1Y
50.7%
Elanco Animal Health
Market Cap: US$12.4b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$25.50
7D
2.7%
1Y
141.7%
Waters
Market Cap: US$29.6b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$302.32
7D
2.5%
1Y
-17.8%